Dr. Prasad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
510 S Kingshighway Blvd
Dept Radiology
Saint Louis, MO 63110Phone+1 314-362-7200Fax+1 314-747-4189
Education & Training
MGM Medical College IndoreClass of 2001
Clinical Trials
- Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE Start of enrollment: 2021 Dec 21
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsFrontiers in radiopharmaceuticals for neuroendocrine tumors.Ameya D Puranik, Indraja D Dev, Vikas Prasad
Journal of Neuroendocrinology. 2025-03-01 - Theranostics in Lung Neuroendocrine Tumors.Indraja D Dev, Ameya D Puranik, Nikolaos A Trikalinos, Bradley John Girod, Hyun Kim
Seminars in Nuclear Medicine. 2025-03-01 - Current and Future Perspectives of PDL1 PET and SPECT Imaging.Indraja D Dev, Ameya D Puranik, Baljinder Singh, Vikas Prasad
Seminars in Nuclear Medicine. 2024-11-01
Press Mentions
PSMA-PET/CT Identifies 'Atypical' Metastases in Prostate Cancer PatientsMarch 21st, 2025- New Analysis Supports Use of FES-PET in Breast Cancer PatientsMarch 13th, 2025
- What’s Your Brain like on a Vanilla Milkshake?March 12th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
